Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VORASIDENIB Cause Aspartate aminotransferase increased? 26 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Aspartate aminotransferase increased have been filed in association with VORASIDENIB (VORANIGO). This represents 9.9% of all adverse event reports for VORASIDENIB.

26
Reports of Aspartate aminotransferase increased with VORASIDENIB
9.9%
of all VORASIDENIB reports
0
Deaths
5
Hospitalizations

How Dangerous Is Aspartate aminotransferase increased From VORASIDENIB?

Of the 26 reports, 5 (19.2%) required hospitalization.

Is Aspartate aminotransferase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VORASIDENIB. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does VORASIDENIB Cause?

Alanine aminotransferase increased (33) Fatigue (27) Malignant neoplasm progression (25) Seizure (21) Hepatic cytolysis (18) Headache (17) Hepatic enzyme increased (17) Gamma-glutamyltransferase increased (16) Nausea (16) Hepatotoxicity (13)

What Other Drugs Cause Aspartate aminotransferase increased?

METHOTREXATE (1,600) RITUXIMAB (1,351) ADALIMUMAB (1,166) TOCILIZUMAB (975) ETANERCEPT (939) ACETAMINOPHEN (865) LEFLUNOMIDE (863) INFLIXIMAB (823) ABATACEPT (778) NIVOLUMAB (758)

Which VORASIDENIB Alternatives Have Lower Aspartate aminotransferase increased Risk?

VORASIDENIB vs VORETIGENE NEPARVOVEC-RZYL VORASIDENIB vs VORICONAZOLE VORASIDENIB vs VORINOSTAT VORASIDENIB vs VORTIOXETINE VORASIDENIB vs VORTIOXETINE HYDROBROMIDE

Related Pages

VORASIDENIB Full Profile All Aspartate aminotransferase increased Reports All Drugs Causing Aspartate aminotransferase increased VORASIDENIB Demographics